Vice President, Technical Operations

Remix launched with a vision to transform patients’ lives through modulation of RNA processing. Our breakthrough science enables the identification of small molecules that influence the expression of disease‑driving mRNAs and proteins. We focus on diseases of high unmet medical need and are committed to operating with scientific rigor and urgency. With a proprietary in‑house technology platform, we have rapidly generated multiple discovery programs advancing toward the clinic. Remix Therapeutics was recognized as one of BioSpace’s Best Places to Work in Boston 2025 and is backed by leading life sciences investors.

Position Summary:

Remix Therapeutics is seeking an experienced and strategic Vice President, Technical Operations to lead the Company's CMC strategy, building and managing a high-performing Technical Operations organization, and overseeing the external manufacturing and supply network required to support late-stage development and future commercial supply of REM-422. This role offers a unique opportunity to shape the operational foundation of a growing biotechnology company at a pivotal stage of development.

The successful candidate will cultivate strategic partnerships with CDMOs, implement scalable operational processes, and establish the standards, systems, and capabilities necessary to support long-term growth. As a member of the Clinical Leadership Team, the Vice President will serve as a key strategic partner across Regulatory Affairs, Quality, Clinical Development, and Executive Leadership, driving operational excellence and enabling the successful delivery of therapies to patients with adenoid cystic carcinoma (ACC) and other serious diseases.

Key Responsibilities:

CMC Strategy & Regulatory Leadership

• Own and drive the CMC lifecycle management for clinical candidate REM-422 and pipeline programs, ensuring alignment with program milestones, corporate objectives, and commercial timelines
• Define and execute a phase-appropriate control strategy, including process and analytical method development, stability programs, specification-setting, PPQ/validation pathway and commercial supply continuity and compliance in alignment with ICH guidelines
• Lead the preparation, authoring, and review of CMC sections for global regulatory submissions including INDs, CTAs/IMPDs, and NDAs/MAAs; serve as primary CMC lead in meetings with Health Authorities in the US and ex-US
• Partner with Regulatory Affairs on CMC strategy, submission timelines, and Health Authority interactions to ensure alignment and on-time delivery of regulatory packages
• Partner with CEO, Regulatory Affairs and Quality Assurance to assist with corporate responses to marketed product defects or recall

CDMO Oversight

• Select and build Remix's external manufacturing network; cultivate strategic partnerships with CDMOs and CMOs through Quality/Technical Agreements (QTAs/TTAs), performance audits, and KPI-driven oversight; oversee product supply chains to ensure continuity and quality <li data-leveltext="•" data-font="" data-listid="2" data-list-defn-props="{"335552541":1,"335559685":540,"335559991":260,"469769242":[8226],"469777803":"left","469777804":"•","469777815":"hybridMultile